Cargando…
Incorporation of apolipoprotein E into HBV–HCV subviral envelope particles to improve the hepatitis vaccine strategy
Hepatitis C is a major threat to public health for which an effective treatment is available, but a prophylactic vaccine is still needed to control this disease. We designed a vaccine based on chimeric HBV–HCV envelope proteins forming subviral particles (SVPs) that induce neutralizing antibodies ag...
Autores principales: | Gomez-Escobar, Elsa, Burlaud-Gaillard, Julien, Visdeloup, Clara, Ribeiro E Silva, Adeline, Coutant, Pauline, Roingeard, Philippe, Beaumont, Elodie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8575973/ https://www.ncbi.nlm.nih.gov/pubmed/34750487 http://dx.doi.org/10.1038/s41598-021-01428-7 |
Ejemplares similares
-
The envelope protein of Zika virus interacts with apolipoprotein E early in the infectious cycle and this interaction is conserved on the secreted viral particles
por: Tréguier, Yannick, et al.
Publicado: (2022) -
Hepatitis B Virus (HBV) Subviral Particles as Protective Vaccines and Vaccine Platforms
por: Ho, Joan Kha-Tu, et al.
Publicado: (2020) -
Subviral Agents
por: STRAUSS, JAMES H., et al.
Publicado: (2008) -
Current Hepatitis C Vaccine Candidates Based on the Induction of Neutralizing Antibodies
por: Gomez-Escobar, Elsa, et al.
Publicado: (2023) -
Direct interaction between the hepatitis B virus core and envelope proteins analyzed in a cellular context
por: Pastor, Florentin, et al.
Publicado: (2019)